AML Rising Star Programme
2144728938
Breast Cancer Rising Star Programme
3094607429

ENDEAVOUR Rising Star Programme is a comprehensive pan-European three years training programme for promising clinicians (up to 15 years of clinical licence) who are keen to further develop their skills as future principle investigators in their respective fields.

There are two dedicated fully funded (by Daiichi Sankyo) ENDEAVOUR programmes; 228-280-7266 and ENDEAVOUR AML for promising breast cancer and leukemia clinicians respectively.

The programme will include annual comprehensive workshops (set up by independent steering committee) with the objective of providing extensive training to talented young clinicians in Europe.

The modules during these workshops will focus on crucial skills and competencies needed to further develop the clinical/research careers of the selected participants. Please find more details on the AML programme here and the Breast programme here.

European Participants

ENDEAVOUR is a pan-European programme that will include a select number of participants from across Europe.

The European mix of promising clinicians will offer the possibility to build-up an international network that may in some instances be the start of long-term European collaborations.

* countries solely included in AML ENDEAVOUR programme

Eligibility Criteria

Doctor

Participants should be talented (maximum 15 years post-residency) licensed haematologists and oncologists.

Bullet 2

Be affiliated to a hospital in one of the following countries: Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and United Kingdom.

Bullet 3

Participants should be employed by a University hospital or academic institution.

Bullet 4

Participants should be employed by a University hospital or academic institution.

Bullet 4